Clarivate Plc (NYSE:CLVT – Get Free Report) insider Bar Veinstein sold 60,000 shares of the business’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $7.00, for a total value of $420,000.00. Following the completion of the transaction, the insider now owns 916,583 shares in the company, valued at $6,416,081. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Bar Veinstein also recently made the following trade(s):
- On Thursday, September 19th, Bar Veinstein sold 120,000 shares of Clarivate stock. The shares were sold at an average price of $7.00, for a total value of $840,000.00.
Clarivate Stock Down 0.1 %
Shares of Clarivate stock opened at $6.70 on Friday. Clarivate Plc has a 12-month low of $4.97 and a 12-month high of $9.60. The company has a quick ratio of 0.90, a current ratio of 0.90 and a debt-to-equity ratio of 0.83. The stock has a 50 day moving average price of $6.62 and a two-hundred day moving average price of $6.39. The stock has a market capitalization of $4.48 billion, a P/E ratio of -4.04 and a beta of 1.17.
Institutional Investors Weigh In On Clarivate
Several hedge funds and other institutional investors have recently made changes to their positions in CLVT. SG Americas Securities LLC bought a new stake in Clarivate during the 2nd quarter valued at approximately $1,410,000. Capital World Investors bought a new stake in shares of Clarivate in the first quarter valued at approximately $30,104,000. Boston Partners grew its stake in shares of Clarivate by 76.3% in the first quarter. Boston Partners now owns 557,496 shares of the company’s stock worth $4,140,000 after acquiring an additional 241,292 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new position in Clarivate during the second quarter worth $2,251,000. Finally, Illinois Municipal Retirement Fund acquired a new position in Clarivate during the 1st quarter valued at $611,000. 85.72% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on CLVT shares. Barclays dropped their price objective on Clarivate from $6.00 to $5.00 and set an “underweight” rating on the stock in a report on Wednesday, August 7th. Royal Bank of Canada cut their price target on shares of Clarivate from $8.00 to $7.00 and set a “sector perform” rating on the stock in a report on Wednesday, August 7th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, Clarivate has an average rating of “Hold” and an average price target of $7.58.
View Our Latest Analysis on Clarivate
About Clarivate
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Featured Stories
- Five stocks we like better than Clarivate
- Airline Stocks – Top Airline Stocks to Buy Now
- Wave Life Sciences Rockets 70% on Historic RNA Editing Success
- What to Know About Investing in Penny Stocks
- UPS vs. FedEx: Which Stock Delivers Better Holiday Gains?
- How to Calculate Stock Profit
- Insider Selling is not a Signal to Start Selling Gartner Stock
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.